NANOG and posterior cortical atrophy: Aberrant expression of the Yamanaka factors and NANOG gene was shown in glioblastoma, breast, lung, colorectal, pancreatic, ovarian cancers, and PCa.8-10NANOG is overexpressed in CSCs, and its inhibition can lead to the death of stem cell-enriched population; thus, it is suggested as a therapeutic target.11